Xlumena, Inc., a leader in the development of advanced endoscopic devices, today announced the close of a $25 million Series C financing. Led by Third Point LLC, the round of funding includes existing ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Boston Scientific is conducting a ...
The RAINBOW study, officially titled “French Prospective Study on Biliary Tract Drainage Guided by Endoscopic Ultrasound in Patients With Malignant Biliary Stenosis (RAINBOW),” evaluates Boston ...
Boston Scientific has signed a definitive agreement to acquire Xlumena, a device company that focuses on the development, manufacture and sale of minimally invasive devices for endoscopic ultrasound.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results